Shore Capital reissued their sell rating on shares of Smith & Nephew (LON:SN) in a report issued on Wednesday, Digital Look reports.
SN has been the subject of several other research reports. Morgan Stanley dropped their price target on shares of Smith & Nephew from GBX 2,165 ($26.64) to GBX 2,150 ($26.46) and set a buy rating for the company in a research report on Thursday, July 9th. UBS Group reissued a neutral rating on shares of Smith & Nephew in a research report on Tuesday, June 23rd. Credit Suisse Group reissued a neutral rating on shares of Smith & Nephew in a research report on Wednesday, July 22nd. Jefferies Financial Group dropped their price target on shares of Smith & Nephew from GBX 2,160 ($26.58) to GBX 1,800 ($22.15) and set a buy rating for the company in a research report on Tuesday, April 28th. Finally, Berenberg Bank decreased their price objective on shares of Smith & Nephew from GBX 2,165 ($26.64) to GBX 2,150 ($26.46) and set a buy rating for the company in a report on Friday, July 10th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of Hold and an average price target of GBX 1,782.25 ($21.93).
Shares of SN opened at GBX 1,517.50 ($18.67) on Wednesday. The stock has a market capitalization of $13.29 billion and a P/E ratio of 22.19. The company has a quick ratio of 0.96, a current ratio of 2.06 and a debt-to-equity ratio of 39.82. The firm has a fifty day simple moving average of GBX 1,587.56 and a two-hundred day simple moving average of GBX 1,632.17. Smith & Nephew has a twelve month low of GBX 14.99 ($0.18) and a twelve month high of GBX 2,023 ($24.90).
The business also recently disclosed a dividend, which will be paid on Wednesday, October 28th. Shareholders of record on Thursday, October 1st will be issued a $0.14 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a yield of 0.68%. Smith & Nephew’s dividend payout ratio (DPR) is presently 43.86%.
In other Smith & Nephew news, insider Roland Diggelmann purchased 2,125 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The stock was bought at an average cost of GBX 1,510 ($18.58) per share, for a total transaction of £32,087.50 ($39,487.45).
Smith & Nephew Company Profile
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Further Reading: How analysts view the yield curve
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.